Lantern Pharma Inc. focuses on the discovery and development of oncology drug in India. Its product pipeline comprises LP-300, which is in phase 2 clinical trial in combination therapy for never-smokers with non-small cell lung cancer adenocarcinoma; LP-184, which is in phase 1a clinical trial for...
3 insider purchases on record · latest filing 2026-05-14.
Insiders have also filed 122 sale transactions at LTRN.